Ερευνητικό υλικό ΕΚΠΑ

Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features

Αγγλικά

Δεν υπάρχει περίληψη

2020

Argyropoulos, K.V.
Pulitzer, M.
Maura, F.
Mohanty, A.
Mondello, P.
Horwitz, S.M.
Myskowski, P.
Moskowitz, A.
Dogan, A.
Querfeld, C.
Rapaport, F.
Siakantaris, M.
Louis, P.C.
Galasso, N.
van den Brink, M.R.M.
Palomba, M.L.

Blood cancer journal

Springer Nature BV

10

11

cyclin dependent kinase inhibitor 2A; cyclin dependent kinase inhibitor 2B; G protein coupled receptor; mitogen activated protein kinase; transcription factor GATA 3, cancer prognosis; clinical feature; cutaneous T cell lymphoma; epigenetics; gene frequency; gene mutation; human; Letter; MAPK signaling; missense mutation; single nucleotide polymorphism; stop codon; systemic therapy; tumor growth; tumor volume; whole exome sequencing; whole genome sequencing; aged; female; genetics; genomics; male; metabolism; middle aged; pathology; skin tumor, Aged; Female; Genomics; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Skin Neoplasms

https://doi.org/10.1038/s41408-020-00380-5

10.1038/s41408-020-00380-5

https://pergamos.lib.uoa.gr/uoa/dl/object/3103641